Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Egypt. J. Exp. Biol. (Zoo.). 2016; 12(1): 93-103


EVALUATION OF THE ROLE OF PROPOLIS AND MYRRAH IN CURING HEPATORENAL TOXICITY INDUCED BY DIABETES IN MICE

Badr G. Moustafa, Alfwuaries M. Abdel Rahman.




Abstract

The aim of the present study is to evaluate the effects of the commonly used honeybee product (propolis) and herbal product (myrrah) in curing the hazardous complications on liver and kidney of diabetic group. The experiment was designed into six groups of adult albino Swiss mice; Control group (C), Diabetic group (D), Propolis (PE) and Myrrha (ME) treated groups (100 mg/kg BW, orally administered for 7 days), and Diabetic group treated with Propolis (DPE) or Myrrha (DME) groups. The study investigated liver and kidneys functions along with histopathological studies, markers for anaemia, tissue interleukins, antioxidants and end product of lipid peroxidation. The present data showed that plasma aspartate transaminase, alanine transaminase, urea and creatinine levels along with conspicuous curing effects in liver and kidneys sections decreased in DPE compared to diabetic group. Modulation of the normocytic/ normochromic anaemia, elevating the tissues Catalase and reducing the superoxide dismutase and malondialdhyde in DPE group. In addition, decrement of IL-6 and increment of IL-10 were detected. Results about treatment with myrrah revealed no improvement in either the liver or the kidneys complications of diabetic mice. The present findings could be considered as a message for diabetic patients to raise their awareness concerning the effectiveness/ineffectiveness of some folk medicine products.

Key words: Propolis, Myrrha, Diabetes, Liver, Kidney, Antioxidants, Anaemia, Interleukins






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.